Amgen Inc
Pharmaceutical & Health Products · Lobbying Client
Amgen Inc's Federal Lobbying Record
At $23.1M in disclosed federal lobbying, Amgen Inc ranks as a major spender — well above the typical filer. Outlays in this range generally reflect a sustained presence in Washington, with at least one full-time government affairs lead and a stable of outside lobbyists engaged on the organization's priority issues.
Across the 5-year window from 2020 to 2024, Amgen Inc's annual disclosed lobbying spend has declined modestly — from $6.0M in 2020 to $3.8M in 2024, a change of -36%. Step-changes of this size often coincide with major bills moving through Congress, regulatory rulemakings affecting the organization's industry, or a leadership change in the relevant committee.
Amgen Inc's disclosed lobbying focuses on a narrow 4-issue footprint. A focused issue list usually means the organization concentrates its federal engagement on a small set of bills or rulemakings directly relevant to its core business.
4 of 15 lobbyists reported by Amgen Inc (27%) disclose prior federal government service. That share is common at established government affairs operations that explicitly hire from agency and committee staff.
Among the named bench, lobbyists with disclosed prior federal service include Lorraine C. Voles (Former Staff Director, House Energy & Commerce Committee); Michelle K. Collins (Former Commissioner, FTC); Thomas J. Quinn (Former Director of Policy, Department of Energy). The covered-position field on LDA cover sheets captures executive-branch and senior congressional roles held within the prior two years.
Within the Pharmaceutical & Health Products sector, Amgen Inc ranks #7 of 34 tracked organizations by disclosed lobbying spend. The sector leader is Pharmaceutical Research & Manufacturers of America at $135.8M; the sector average is $16.7M. Amgen Inc's $23.1M sits 38% above the sector average.
Amgen Inc's LobbySpend Influence Score of 54/100 (grade C) is the most common grade in the index — it covers organizations with established but moderate federal advocacy programs. The score combines disclosed total spend (40%), issue breadth (30%), and revolving-door connections (30%). A C-grade is typical of mid-size corporations and trade associations with steady quarterly filings on a focused issue set.
Every figure above is sourced from Senate lobbying disclosure filings submitted under the Lobbying Disclosure Act of 1995. Per-issue dollar splits and covered-position flags are filer-reported and may be amended after initial submission.
Track Amgen Inc's lobbying filings
Subscribe for LobbySpend updates by email. No spam, unsubscribe anytime.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2024 Oct-Dec | Capitol Counsel | MEDHCRPHA | 1 | $1.1M |
| 2024 Jul-Sep | Hogan Lovells | HCRPHAGOV | 4 | $1.0M |
| 2024 Apr-Jun | Jones Day | GOVMEDPHA | 1 | $891K |
| 2024 Jan-Mar | Fierce Government Relations | MEDHCRGOV | 2 | $838K |
| 2023 Oct-Dec | Brownstein Hyatt Farber Schreck | MEDHCRPHA+1 | 4 | $729K |
| 2023 Jul-Sep | Akin Gump Strauss Hauer & Feld | GOVPHA | 3 | $996K |
| 2023 Apr-Jun | Cornerstone Government Affairs | PHAHCRGOV+1 | 3 | $1.0M |
| 2023 Jan-Mar | Akin Gump Strauss Hauer & Feld | PHAMED | 2 | $1.0M |
Amgen Inc Lobbying FAQ
Amgen Inc has spent $23.1M on federal lobbying across 4 policy areas. This includes spending on registered lobbyists and direct government contacts.
Amgen Inc lobbies on 4 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Government Issues. These disclosures are filed quarterly with the Senate Office of Public Records.
Amgen Inc has an Influence Score of 54/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).
Amgen Inc employs 15 registered lobbyists, of whom 4 have revolving door connections, meaning they previously held government positions before becoming lobbyists.
Amgen Inc has contacted 5 government entities as part of their lobbying activities, including Office of the U.S. Trade Representative, Dept of Energy, National Science Foundation.
Explore Other Lobbying Organizations
$387.8M lobbying spend · Trade Association · Influence Score B
$348.2M lobbying spend · Real Estate · Influence Score B
$135.8M lobbying spend · Pharmaceutical & Health Products · Influence Score B
$128.0M lobbying spend · Healthcare · Influence Score B
Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.